Luye Pharmaceutical Group

Luye Pharmaceutical Group is an international pharmaceutical company established in 1994, headquartered in Shanghai, China. It strategically focuses on developing and commercializing innovative medications targeting central nervous system (CNS) disorders and oncology, alongside other critical therapeutic areas. The company's operational model is built upon three core pillars: global research and development (R&D), global manufacturing capabilities, and worldwide sales of its pharmaceutical products. This integrated approach allows Luye Pharma to address unmet medical needs across diverse patient populations and geographies.

With a global footprint spanning 6 locations, Luye Pharmaceutical Group employs a substantial workforce ranging from 5,000-10,000 individuals dedicated to advancing healthcare solutions. The company's commitment to innovation is driven by its extensive R&D efforts and its global team, which collaborates to bring novel therapies from discovery to market. Meet Luye Pharmaceutical Group's team to understand the expertise driving these international operations and product development initiatives.

The company generated a revenue of $843.8M, underscoring its significant market presence within the healthcare and pharmaceutical sectors. Luye Pharmaceutical Group's product portfolio includes innovative pharmaceuticals and R&D-driven medications, reflecting its dedication to scientific advancement and patient well-being. Its strategic priorities ensure a continuous pipeline of therapeutic solutions designed to improve health outcomes globally.